Correction: Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis - Top-Institutions - MDSpire

Correction: A Network Meta-Analysis Comparing Glucagon-Like Peptide-1 Receptor Agonists, Metformin, and Inositol on Anthropometric and Metabolic Improvements in Women with Polycystic Ovary Syndrome

  • By

  • Asad Omarion

  • Yaman Ayasa

  • Zainab Omarion

  • Batoul Jayouse

  • Hazem Ayesh

  • July 20, 2026

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Metabolism

  • #2

    NewYork-Presbyterian Hospital
    NewYork-Presbyterian Hospital

    New York, New York

    Key Differentiators

    • Endocrinology
    • Diabetes

Original Source(s)

Correction: Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis

  • by Asad Omarion, Yaman Ayasa, Zainab Omarion, Batoul Jayouse, Hazem Ayesh

  • July 20, 2026

Related Content

Interpretable machine learning for presurgical differentiation of Hürthle cell carcinoma and adenoma: a SHAP-augmented approach

GLP-1 receptor agonists and psychiatric outcomes: a bibliometric analysis of research trends, thematic evolution, and collaboration networks

Factors associated with levothyroxine withdrawal and development of a prediction model in primary hypothyroidism